Augmedix, Inc.

AUGX · NASDAQ
Analyze with AI
6/30/2024
3/31/2024
12/31/2023
9/30/2023
Operating Activities
Net Income-$8-$6-$4-$4
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0-$1-$2
Stock-Based Comp.$1$1$1$1
Change in WC$2-$4$2$1
Other Non-Cash$2$3$2$2
Operating Cash Flow-$4-$8-$1-$2
Investing Activities
PP&E Inv.-$0-$1-$1-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$1-$1-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$27-$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0-$1$0
Financing Cash Flow$0$0$26$0
Forex Effect-$0$0-$0-$0
Net Chg. in Cash-$9-$9$25-$3
Supplemental Information
Beg. Cash$37$46$22$25
End Cash$28$37$46$22
Free Cash Flow-$4-$9-$2-$3
Augmedix, Inc. (AUGX) Financial Statements & Key Stats | AlphaPilot